BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27939749)

  • 1. Mining the Unknown: Assigning Function to Noncoding Single Nucleotide Polymorphisms.
    Nishizaki SS; Boyle AP
    Trends Genet; 2017 Jan; 33(1):34-45. PubMed ID: 27939749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating regulatory features data for prediction of functional disease-associated SNPs.
    Dong SS; Guo Y; Yao S; Chen YX; He MN; Zhang YJ; Chen XF; Chen JB; Yang TL
    Brief Bioinform; 2019 Jan; 20(1):26-32. PubMed ID: 28968709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method to predict the impact of regulatory variants from DNA sequence.
    Lee D; Gorkin DU; Baker M; Strober BJ; Asoni AL; McCallion AS; Beer MA
    Nat Genet; 2015 Aug; 47(8):955-61. PubMed ID: 26075791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GERV: a statistical method for generative evaluation of regulatory variants for transcription factor binding.
    Zeng H; Hashimoto T; Kang DD; Gifford DK
    Bioinformatics; 2016 Feb; 32(4):490-6. PubMed ID: 26476779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico analysis of inflammatory bowel disease (IBD) GWAS loci to novel connections.
    Mesbah-Uddin M; Elango R; Banaganapalli B; Shaik NA; Al-Abbasi FA
    PLoS One; 2015; 10(3):e0119420. PubMed ID: 25786114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Res2s2aM: Deep residual network-based model for identifying functional noncoding SNPs in trait-associated regions.
    Liu Z; Yao Y; Wei Q; Weeder B; Ramsey SA
    Pac Symp Biocomput; 2019; 24():76-87. PubMed ID: 30864312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and progress in interpretation of non-coding genetic variants associated with human disease.
    Zhu Y; Tazearslan C; Suh Y
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1325-1334. PubMed ID: 28581336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a
    Rosier F; Brisebarre A; Dupuis C; Baaklini S; Puthier D; Brun C; Pradel LC; Rihet P; Payen D
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating genome wide association study results to associations among common diseases: in silico study with an electronic medical record.
    Anand V; Rosenman MB; Downs SM
    Int J Med Inform; 2013 Sep; 82(9):864-74. PubMed ID: 23743324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-Skewed DNA Modification in the Brain: Relevance to a Schizophrenia GWAS.
    Gagliano SA; Ptak C; Mak DYF; Shamsi M; Oh G; Knight J; Boutros PC; Petronis A
    Am J Hum Genet; 2016 May; 98(5):956-962. PubMed ID: 27087318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer.
    Heyn H
    PLoS Genet; 2016 Mar; 12(3):e1005826. PubMed ID: 26938653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convolutional neural network model to predict causal risk factors that share complex regulatory features.
    Lee T; Sung MK; Lee S; Yang W; Oh J; Kim JY; Hwang S; Ban HJ; Choi JK
    Nucleic Acids Res; 2019 Dec; 47(22):e146. PubMed ID: 31598692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of noncoding genome annotation tools through enrichment analysis of 15 genome-wide association studies.
    Li B; Lu Q; Zhao H
    Brief Bioinform; 2019 May; 20(3):995-1003. PubMed ID: 29106447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.
    Dennis J; Medina-Rivera A; Truong V; Antounians L; Zwingerman N; Carrasco G; Strug L; Wells P; Trégouët DA; Morange PE; Wilson MD; Gagnon F
    Genet Epidemiol; 2017 Jul; 41(5):455-466. PubMed ID: 28421636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3DSNP: a database for linking human noncoding SNPs to their three-dimensional interacting genes.
    Lu Y; Quan C; Chen H; Bo X; Zhang C
    Nucleic Acids Res; 2017 Jan; 45(D1):D643-D649. PubMed ID: 27789693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which Genetics Variants in DNase-Seq Footprints Are More Likely to Alter Binding?
    Moyerbrailean GA; Kalita CA; Harvey CT; Wen X; Luca F; Pique-Regi R
    PLoS Genet; 2016 Feb; 12(2):e1005875. PubMed ID: 26901046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-annotation of presumed noncoding disease/trait-associated genetic variants by integrative analyses.
    Chen G; Yu D; Chen J; Cao R; Yang J; Wang H; Ji X; Ning B; Shi T
    Sci Rep; 2015 Mar; 5():9453. PubMed ID: 25819875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond GWASs: illuminating the dark road from association to function.
    Edwards SL; Beesley J; French JD; Dunning AM
    Am J Hum Genet; 2013 Nov; 93(5):779-97. PubMed ID: 24210251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human aging in the post-GWAS era: further insights reveal potential regulatory variants.
    Haider SA; Faisal M
    Biogerontology; 2015 Aug; 16(4):529-41. PubMed ID: 25895066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Running spell-check to identify regulatory variants.
    Kircher M; Shendure J
    Nat Genet; 2015 Aug; 47(8):853-5. PubMed ID: 26220134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.